http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08509462-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-535 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
| filingDate | 1994-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1996-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H08509462-A |
| titleOfInvention | Pharmaceutical composition containing 5-morpholinomethyl-3- (4-chlorobenzylideneamine) -2-oxazolidinone and use for the treatment of CNS disorders |
| abstract | (57) Summary A pharmaceutically acceptable carrier and, if necessary, an auxiliary, as an active substance, a compound of formula I: -Morpholinomethyl-3- (4-chlorobenzylideneamine) -2-oxazolidinone and / or a pharmaceutically acceptable salt thereof and / or a pharmaceutically acceptable salt thereof and a central agent thereof It describes the use of 5-morpholinomethyl-3- (4-chlorobenzylideneamine) -2-oxazolidinone for the manufacture of a medicament having nervous system activity. |
| priorityDate | 1993-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.